Data Acquisition for Optimization of Coronary Artery Disease (CAD) Algorithm
NCT ID: NCT01564628
Last Updated: 2019-08-19
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
306 participants
OBSERVATIONAL
2012-03-31
2013-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Postapproval Trial On Carotid Stenting in Patients With High Risk Vs Standard Risk for Open Carotid Endarterectomy(REAL)
NCT02750644
Robustness Check of Placement and Measurement Algorithms for Blood Flow Measurement on Common Carotid Artery
NCT05193760
Quantitative Coronary Angiography Versus Imaging GUIDancE for Bioresorbable Vascular Scaffold Implantation
NCT02831218
Ambulatory Blood Pressure Monitoring in Patients With Coronary Artery Disease
NCT04649463
Whole Blood Transcriptomic Signal According to Coronary Atherosclerotic Plaque Burden Assessed by CT Angiography
NCT06194526
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
All study participants
Population from 2 sites, sequential design with all patients undergoing CADScor1 intervention followed by the diagnostic testing the patients were referred to (procedure done according to standard of care and not part of study; computerized tomographic angiography (CTA) and, if relevant, coronary angiography (CAG) at Site 1 and CAG at site 2).
CADScor1
Acoustic recording
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CADScor1
Acoustic recording
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Referred to diagnostically Ca-CT, CT scan and/or CAG examination due to suspicion of coronary artery disease
* Subjects condition must be stable and the subject must not be referred due to suspicion of acute coronary syndrome
* Subject is willing to adhere to the study procedure
* Has signed the informed consent form and authorization to registration and publication of health information
Exclusion Criteria
* Arterial fibrillation
* Known severe arrhythmia or resting heart rate above 85 bpm
* Known diastolic murmurs due to heart valve disease
* Has had a previous by-pass operation, open chest surgery, donor heart or mechanical heart
* Reduced ejection fraction \< 50%
* Inability to understand or adhere to instructions for acoustic Data-acquisition (i.e. subject not able to hold breath due to KOL or asthma)
* Inability to perform CT-angio and/or subsequent CAG
* In active treatment for any cancer
* In active treatment for immunosuppression after transplantation
* Established or pursuing pregnancy or breast feeding
* Has damaged skin on the spot where the patch is placed during the recordings.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Acarix
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Morten Bøttcher, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital of Aarhus, Skejby
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Aarhus, Skejby
Aarhus N, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AC003-SH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.